POLB — Poolbeg Pharma Share News
0.000.00%
Last trade - 00:00- £53.00m
- £38.88m
REG - Poolbeg Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Poolbeg Pharma PLC - Director Share Purchase
AnnouncementREG - Poolbeg Pharma PLC - Board Role Change and Launch of EIP
AnnouncementREG - Poolbeg Pharma PLC - Market Opportunity for POLB 001 for CRS
AnnouncementREG - Poolbeg Pharma PLC - Further data shows POLB001 potential in cancer CRS
AnnouncementREG - Poolbeg Pharma PLC - RSV AI Drug Candidate Analysis Update
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 Data Presented at ASH
AnnouncementREG - Poolbeg Pharma PLC - Directorate Change
AnnouncementRCS - Poolbeg Pharma PLC - Immunomodulator II patent granted in Japan
AnnouncementRCS - Poolbeg Pharma PLC - POLB 001 LPS Trial Data to be Presented at IUIS
AnnouncementREG - Poolbeg Pharma PLC - Former Amryt Pharma Leadership Team join Poolbeg
AnnouncementREG - Poolbeg Pharma PLC - POLB001 Data to be Presented at ASH Annual Meeting
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 Oncology Programme Update Meeting
AnnouncementRCS - Poolbeg Pharma PLC - SAB Endorses Influenza Drug Targets
AnnouncementREG - Poolbeg Pharma PLC - Poolbeg Partners with a Nasdaq-Listed Biopharma
AnnouncementREG - Poolbeg Pharma PLC - Favourable Conclusion of Patent Opposition
AnnouncementRCS - Poolbeg Pharma PLC - Immunomodulator I Patent Portfolio Strengthened
AnnouncementREG - Poolbeg Pharma PLC - Immunomodulator I Patent Opposition Withdrawal
AnnouncementREG - Poolbeg Pharma PLC - Interim results for the six months to 30 June 2023
Announcement